Affinity DataKi: 0.970nMAssay Description:Binding affinity towards human histamine H1 receptor expressed in CHO-K1 cellsMore data for this Ligand-Target Pair
Affinity DataKi: 9nMAssay Description:Binding affinity towards human histamine H1 receptor expressed in CHO-K1 cellsMore data for this Ligand-Target Pair
Affinity DataKi: 14nMAssay Description:Binding affinity towards human histamine H1 receptor expressed in CHO-K1 cellsMore data for this Ligand-Target Pair
Affinity DataKi: 14nMAssay Description:Binding affinity towards human histamine H1 receptor expressed in CHO-K1 cellsMore data for this Ligand-Target Pair
Affinity DataKi: 19nMAssay Description:Binding affinity towards human histamine H1 receptor expressed in CHO-K1 cellsMore data for this Ligand-Target Pair
Affinity DataKi: 26nMAssay Description:Binding affinity towards human histamine H1 receptor expressed in CHO-K1 cellsMore data for this Ligand-Target Pair
Affinity DataKi: 30nMAssay Description:Binding affinity towards human histamine H1 receptor expressed in CHO-K1 cellsMore data for this Ligand-Target Pair
Affinity DataKi: 50nMAssay Description:Binding affinity towards human histamine H1 receptor expressed in CHO-K1 cellsMore data for this Ligand-Target Pair
Affinity DataKi: 109nMAssay Description:Binding affinity towards human histamine H1 receptor expressed in CHO-K1 cellsMore data for this Ligand-Target Pair
Affinity DataKi: 295nMAssay Description:Binding affinity towards human histamine H1 receptor expressed in CHO-K1 cellsMore data for this Ligand-Target Pair
Affinity DataKi: 305nMAssay Description:Binding affinity towards human histamine H1 receptor expressed in CHO-K1 cellsMore data for this Ligand-Target Pair
Affinity DataKi: 414nMAssay Description:Binding affinity towards human histamine H1 receptor expressed in CHO-K1 cellsMore data for this Ligand-Target Pair
TargetC-X-C chemokine receptor type 2(Homo sapiens (Human))
Gsk Pharmaceuticals R & D
Curated by ChEMBL
Gsk Pharmaceuticals R & D
Curated by ChEMBL
Affinity DataIC50: 0.158nMAssay Description:Antagonist activity at TEV protease cleavage site linked GAL4-VP16-fused recombinant human CXCR2 expressed in cells assessed as inhibition of TEV pro...More data for this Ligand-Target Pair
TargetC-X-C chemokine receptor type 2(Homo sapiens (Human))
Gsk Pharmaceuticals R & D
Curated by ChEMBL
Gsk Pharmaceuticals R & D
Curated by ChEMBL
Affinity DataIC50: 0.200nMAssay Description:Agonist activity at CXCR3 (unknown origin)More data for this Ligand-Target Pair
TargetC-X-C chemokine receptor type 2(Homo sapiens (Human))
Gsk Pharmaceuticals R & D
Curated by ChEMBL
Gsk Pharmaceuticals R & D
Curated by ChEMBL
Affinity DataIC50: 0.200nMAssay Description:Agonist activity at CCR10 (unknown origin)More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase mTOR(Homo sapiens (Human))
China Pharmaceutical University
Curated by ChEMBL
China Pharmaceutical University
Curated by ChEMBL
Affinity DataIC50: 0.25nMAssay Description:Inhibition of mTOR (unknown origin)More data for this Ligand-Target Pair
TargetC-X-C chemokine receptor type 2(Homo sapiens (Human))
Gsk Pharmaceuticals R & D
Curated by ChEMBL
Gsk Pharmaceuticals R & D
Curated by ChEMBL
Affinity DataIC50: 0.251nMAssay Description:Antagonist activity at TEV protease cleavage site linked GAL4-VP16-fused recombinant human CXCR2 expressed in cells assessed as inhibition of TEV pro...More data for this Ligand-Target Pair
TargetC-X-C chemokine receptor type 2(Homo sapiens (Human))
Gsk Pharmaceuticals R & D
Curated by ChEMBL
Gsk Pharmaceuticals R & D
Curated by ChEMBL
Affinity DataIC50: 0.251nMAssay Description:Antagonist activity at TEV protease cleavage site linked GAL4-VP16-fused recombinant human CXCR2 expressed in cells assessed as inhibition of TEV pro...More data for this Ligand-Target Pair
TargetC-X-C chemokine receptor type 2(Homo sapiens (Human))
Gsk Pharmaceuticals R & D
Curated by ChEMBL
Gsk Pharmaceuticals R & D
Curated by ChEMBL
Affinity DataIC50: 0.251nMAssay Description:Antagonist activity at TEV protease cleavage site linked GAL4-VP16-fused recombinant human CXCR2 expressed in cells assessed as inhibition of TEV pro...More data for this Ligand-Target Pair
TargetC-X-C chemokine receptor type 2(Homo sapiens (Human))
Gsk Pharmaceuticals R & D
Curated by ChEMBL
Gsk Pharmaceuticals R & D
Curated by ChEMBL
Affinity DataIC50: 0.316nMAssay Description:Antagonist activity at human recombinant Gal4-VP16 fused-CXCR2 assessed as inhibition of CXCL1-mediated lactamase reporter gene expression after over...More data for this Ligand-Target Pair
TargetC-X-C chemokine receptor type 2(Homo sapiens (Human))
Gsk Pharmaceuticals R & D
Curated by ChEMBL
Gsk Pharmaceuticals R & D
Curated by ChEMBL
Affinity DataIC50: 0.316nMAssay Description:Antagonist activity at human recombinant Gal4-VP16 fused-CXCR2 assessed as inhibition of CXCL1-mediated lactamase reporter gene expression after over...More data for this Ligand-Target Pair
TargetC-X-C chemokine receptor type 2(Homo sapiens (Human))
Gsk Pharmaceuticals R & D
Curated by ChEMBL
Gsk Pharmaceuticals R & D
Curated by ChEMBL
Affinity DataIC50: 0.316nMAssay Description:Agonist activity at CCR9 (unknown origin)More data for this Ligand-Target Pair
TargetC-X-C chemokine receptor type 2(Homo sapiens (Human))
Gsk Pharmaceuticals R & D
Curated by ChEMBL
Gsk Pharmaceuticals R & D
Curated by ChEMBL
Affinity DataIC50: 0.316nMAssay Description:Antagonist activity at human recombinant Gal4-VP16 fused-CXCR2 assessed as inhibition of CXCL1-mediated lactamase reporter gene expression after over...More data for this Ligand-Target Pair
TargetC-X-C chemokine receptor type 2(Homo sapiens (Human))
Gsk Pharmaceuticals R & D
Curated by ChEMBL
Gsk Pharmaceuticals R & D
Curated by ChEMBL
Affinity DataIC50: 0.398nMAssay Description:Antagonist activity at TEV protease cleavage site linked GAL4-VP16-fused recombinant human CXCR2 expressed in cells assessed as inhibition of TEV pro...More data for this Ligand-Target Pair
TargetC-X-C chemokine receptor type 2(Homo sapiens (Human))
Gsk Pharmaceuticals R & D
Curated by ChEMBL
Gsk Pharmaceuticals R & D
Curated by ChEMBL
Affinity DataIC50: 0.398nMAssay Description:Antagonist activity at TEV protease cleavage site linked GAL4-VP16-fused recombinant human CXCR2 expressed in cells assessed as inhibition of TEV pro...More data for this Ligand-Target Pair
TargetC-X-C chemokine receptor type 2(Homo sapiens (Human))
Gsk Pharmaceuticals R & D
Curated by ChEMBL
Gsk Pharmaceuticals R & D
Curated by ChEMBL
Affinity DataIC50: 0.398nMAssay Description:Antagonist activity at TEV protease cleavage site linked GAL4-VP16-fused recombinant human CXCR2 expressed in cells assessed as inhibition of TEV pro...More data for this Ligand-Target Pair
TargetC-X-C chemokine receptor type 2(Homo sapiens (Human))
Gsk Pharmaceuticals R & D
Curated by ChEMBL
Gsk Pharmaceuticals R & D
Curated by ChEMBL
Affinity DataIC50: 0.398nMAssay Description:Antagonist activity at human recombinant Gal4-VP16 fused-CXCR2 assessed as inhibition of CXCL1-mediated lactamase reporter gene expression after over...More data for this Ligand-Target Pair
TargetC-X-C chemokine receptor type 2(Homo sapiens (Human))
Gsk Pharmaceuticals R & D
Curated by ChEMBL
Gsk Pharmaceuticals R & D
Curated by ChEMBL
Affinity DataIC50: 0.398nMAssay Description:Antagonist activity at TEV protease cleavage site linked GAL4-VP16-fused recombinant human CXCR2 expressed in cells assessed as inhibition of TEV pro...More data for this Ligand-Target Pair
TargetC-X-C chemokine receptor type 2(Homo sapiens (Human))
Gsk Pharmaceuticals R & D
Curated by ChEMBL
Gsk Pharmaceuticals R & D
Curated by ChEMBL
Affinity DataIC50: 0.398nMAssay Description:Antagonist activity at human recombinant Gal4-VP16 fused-CXCR2 assessed as inhibition of CXCL1-mediated lactamase reporter gene expression after over...More data for this Ligand-Target Pair
TargetEpidermal growth factor receptor(Homo sapiens (Human))
Beijing Institute Of Pharmacology And Toxicology
Curated by ChEMBL
Beijing Institute Of Pharmacology And Toxicology
Curated by ChEMBL
Affinity DataIC50: 0.414nMAssay Description:Inhibition of EGFR T790M/C797S double mutant (unknown origin) using flurogenic substrate in presence of ATP by HTRF assayMore data for this Ligand-Target Pair
Affinity DataIC50: 0.501nMAssay Description:Inhibition of PHD2 (unknown origin) by HTRF assayMore data for this Ligand-Target Pair
TargetC-X-C chemokine receptor type 2(Homo sapiens (Human))
Gsk Pharmaceuticals R & D
Curated by ChEMBL
Gsk Pharmaceuticals R & D
Curated by ChEMBL
Affinity DataIC50: 0.501nMAssay Description:Antagonist activity at TEV protease cleavage site linked GAL4-VP16-fused recombinant human CXCR2 expressed in cells assessed as inhibition of TEV pro...More data for this Ligand-Target Pair
TargetC-X-C chemokine receptor type 2(Homo sapiens (Human))
Gsk Pharmaceuticals R & D
Curated by ChEMBL
Gsk Pharmaceuticals R & D
Curated by ChEMBL
Affinity DataIC50: 0.501nMAssay Description:Antagonist activity at human recombinant Gal4-VP16 fused-CXCR2 assessed as inhibition of CXCL1-mediated lactamase reporter gene expression after over...More data for this Ligand-Target Pair
TargetC-X-C chemokine receptor type 2(Homo sapiens (Human))
Gsk Pharmaceuticals R & D
Curated by ChEMBL
Gsk Pharmaceuticals R & D
Curated by ChEMBL
Affinity DataIC50: 0.501nMAssay Description:Antagonist activity at human recombinant Gal4-VP16 fused-CXCR2 assessed as inhibition of CXCL1-mediated lactamase reporter gene expression after over...More data for this Ligand-Target Pair
TargetC-X-C chemokine receptor type 2(Homo sapiens (Human))
Gsk Pharmaceuticals R & D
Curated by ChEMBL
Gsk Pharmaceuticals R & D
Curated by ChEMBL
Affinity DataIC50: 0.501nMAssay Description:Antagonist activity at human recombinant Gal4-VP16 fused-CXCR2 assessed as inhibition of CXCL1-mediated lactamase reporter gene expression after over...More data for this Ligand-Target Pair
TargetC-X-C chemokine receptor type 2(Homo sapiens (Human))
Gsk Pharmaceuticals R & D
Curated by ChEMBL
Gsk Pharmaceuticals R & D
Curated by ChEMBL
Affinity DataIC50: 0.501nMAssay Description:Antagonist activity at TEV protease cleavage site linked GAL4-VP16-fused recombinant human CXCR2 expressed in cells assessed as inhibition of TEV pro...More data for this Ligand-Target Pair
TargetC-X-C chemokine receptor type 2(Homo sapiens (Human))
Gsk Pharmaceuticals R & D
Curated by ChEMBL
Gsk Pharmaceuticals R & D
Curated by ChEMBL
Affinity DataIC50: 0.501nMAssay Description:Antagonist activity at human recombinant Gal4-VP16 fused-CXCR2 assessed as inhibition of CXCL1-mediated lactamase reporter gene expression after over...More data for this Ligand-Target Pair
TargetC-X-C chemokine receptor type 2(Homo sapiens (Human))
Gsk Pharmaceuticals R & D
Curated by ChEMBL
Gsk Pharmaceuticals R & D
Curated by ChEMBL
Affinity DataIC50: 0.501nMAssay Description:Antagonist activity at CXCR5 (unknown origin)More data for this Ligand-Target Pair
TargetC-X-C chemokine receptor type 2(Homo sapiens (Human))
Gsk Pharmaceuticals R & D
Curated by ChEMBL
Gsk Pharmaceuticals R & D
Curated by ChEMBL
Affinity DataIC50: 0.501nMAssay Description:Antagonist activity at human recombinant Gal4-VP16 fused-CXCR2 assessed as inhibition of CXCL1-mediated lactamase reporter gene expression after over...More data for this Ligand-Target Pair
TargetC-X-C chemokine receptor type 2(Homo sapiens (Human))
Gsk Pharmaceuticals R & D
Curated by ChEMBL
Gsk Pharmaceuticals R & D
Curated by ChEMBL
Affinity DataIC50: 0.501nMAssay Description:Antagonist activity at human recombinant Gal4-VP16 fused-CXCR2 assessed as inhibition of CXCL1-mediated lactamase reporter gene expression after over...More data for this Ligand-Target Pair
TargetC-X-C chemokine receptor type 2(Homo sapiens (Human))
Gsk Pharmaceuticals R & D
Curated by ChEMBL
Gsk Pharmaceuticals R & D
Curated by ChEMBL
Affinity DataIC50: 0.501nMAssay Description:Antagonist activity at human recombinant Gal4-VP16 fused-CXCR2 assessed as inhibition of CXCL1-mediated lactamase reporter gene expression after over...More data for this Ligand-Target Pair
TargetC-X-C chemokine receptor type 2(Homo sapiens (Human))
Gsk Pharmaceuticals R & D
Curated by ChEMBL
Gsk Pharmaceuticals R & D
Curated by ChEMBL
Affinity DataIC50: 0.501nMAssay Description:Antagonist activity at TEV protease cleavage site linked GAL4-VP16-fused recombinant human CXCR2 expressed in cells assessed as inhibition of TEV pro...More data for this Ligand-Target Pair
TargetC-X-C chemokine receptor type 2(Homo sapiens (Human))
Gsk Pharmaceuticals R & D
Curated by ChEMBL
Gsk Pharmaceuticals R & D
Curated by ChEMBL
Affinity DataIC50: 0.501nMAssay Description:Antagonist activity at human recombinant Gal4-VP16 fused-CXCR2 assessed as inhibition of CXCL1-mediated lactamase reporter gene expression after over...More data for this Ligand-Target Pair
TargetC-X-C chemokine receptor type 2(Homo sapiens (Human))
Gsk Pharmaceuticals R & D
Curated by ChEMBL
Gsk Pharmaceuticals R & D
Curated by ChEMBL
Affinity DataIC50: 0.631nMAssay Description:Antagonist activity at human recombinant Gal4-VP16 fused-CXCR2 assessed as inhibition of CXCL1-mediated lactamase reporter gene expression after over...More data for this Ligand-Target Pair
TargetC-X-C chemokine receptor type 2(Homo sapiens (Human))
Gsk Pharmaceuticals R & D
Curated by ChEMBL
Gsk Pharmaceuticals R & D
Curated by ChEMBL
Affinity DataIC50: 0.631nMAssay Description:Agonist activity at CXCR7 (unknown origin)More data for this Ligand-Target Pair
TargetC-X-C chemokine receptor type 2(Homo sapiens (Human))
Gsk Pharmaceuticals R & D
Curated by ChEMBL
Gsk Pharmaceuticals R & D
Curated by ChEMBL
Affinity DataIC50: 0.631nMAssay Description:Agonist activity at CCR8 (unknown origin)More data for this Ligand-Target Pair
TargetC-X-C chemokine receptor type 2(Homo sapiens (Human))
Gsk Pharmaceuticals R & D
Curated by ChEMBL
Gsk Pharmaceuticals R & D
Curated by ChEMBL
Affinity DataIC50: 0.631nMAssay Description:Antagonist activity at human recombinant Gal4-VP16 fused-CXCR2 assessed as inhibition of CXCL1-mediated lactamase reporter gene expression after over...More data for this Ligand-Target Pair
TargetC-X-C chemokine receptor type 2(Homo sapiens (Human))
Gsk Pharmaceuticals R & D
Curated by ChEMBL
Gsk Pharmaceuticals R & D
Curated by ChEMBL
Affinity DataIC50: 0.794nMAssay Description:Antagonist activity at human recombinant Gal4-VP16 fused-CXCR2 assessed as inhibition of CXCL1-mediated lactamase reporter gene expression after over...More data for this Ligand-Target Pair
TargetC-X-C chemokine receptor type 2(Homo sapiens (Human))
Gsk Pharmaceuticals R & D
Curated by ChEMBL
Gsk Pharmaceuticals R & D
Curated by ChEMBL
Affinity DataIC50: 0.794nMAssay Description:Antagonist activity at TEV protease cleavage site linked GAL4-VP16-fused recombinant human CXCR2 expressed in cells assessed as inhibition of TEV pro...More data for this Ligand-Target Pair
TargetC-X-C chemokine receptor type 2(Homo sapiens (Human))
Gsk Pharmaceuticals R & D
Curated by ChEMBL
Gsk Pharmaceuticals R & D
Curated by ChEMBL
Affinity DataIC50: 0.794nMAssay Description:Antagonist activity at human recombinant Gal4-VP16 fused-CXCR2 assessed as inhibition of CXCL1-mediated lactamase reporter gene expression after over...More data for this Ligand-Target Pair